283 results
Approved WMORecruitment stopped
To study the renal safety when HIV patients with TDF related renal toxicity switch to TAF compared to the current practice of switching to ABC.
Approved WMOWill not start
Primary Objective: To isolate B-cells producing bNAbs against EVs from healthy human individuals and to generate bNAbs from these B-cells for the development of a novel EV immunotherapy. Secondary Objective(s): To further elucidate the humoral…
Approved WMOCompleted
Primary objective:To assess the bioequivalence of single-dose velpatasvir administered as a fixed-dose combination of sofosbuvir/velpatasvir (SOF/VEL; Epclusa®) when given with cola + omeprazole 40mg (test 1/trt A) compared to velpatasvir…